Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 75 6
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021 38 47
Ebastine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021 1 0
Doxycycline Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/14/2021 6 0
Bepridil Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/17/2021 1 0
Rupintrivir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/27/2021 2 1
Almitrine Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/21/2020 3 0
Ad5-nCoV Potential treatment - clinical evidence Experimental Vaccine Aug/14/2020 4 0
CbAE-2 Potential treatment - pre-clinical evidence Natural product Antiviral May/22/2020 1 0
Excel (.xslx) CSV (.csv)